Author: Andrew A. Lover
Title: Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial (Gautret et al, 2020) Document date: 2020_3_27
ID: azvbl4ie_17
Snippet: This analysis is not without limitations: interpretation of the presented dataset may be incorrect; the analysis models for the primary and secondary outcome endpoints is inferred from the original authors' description and power calcualtions (case-control design); and not all covariates were available in the original data [12] ......
Document: This analysis is not without limitations: interpretation of the presented dataset may be incorrect; the analysis models for the primary and secondary outcome endpoints is inferred from the original authors' description and power calcualtions (case-control design); and not all covariates were available in the original data [12] .
Search related documents:
Co phrase search for related documents- analysis model and case control design: 1, 2, 3
- analysis model and present dataset: 1, 2
- analysis model and secondary primary outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9
- case control and secondary primary outcome: 1, 2, 3, 4, 5, 6, 7
- case control design and secondary primary outcome: 1
Co phrase search for related documents, hyperlinks ordered by date